Tumor necrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
350
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Childhood Alveolar Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
59
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Childhood Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
477
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
stage, neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
27
|
4
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Adenocarcinoma in Situ
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
55
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
593
|
24
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Primary sclerosing cholangitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
264
|
58
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Nasal and nasal-type NK/T-cell lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Ewings sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
25
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Hypoganglionosis
|
disease |
|
Disease or Syndrome
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pervasive Development Disorder
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
328
|
49
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Squamous cell carcinoma of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
458
|
92
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lymphoma of colon
|
disease |
Digestive System Diseases; Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Lymphadenopathy
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
277
|
5
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1597
|
326
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Follicular neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
68
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Light chain myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Post-transplant lymphoproliferative disorder
|
disease |
Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
2
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Bladder Paraganglioma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Plasma cell inflammation
|
disease |
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Hematopoietic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
322
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2014 |
2014 |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
467
|
14
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent Childhood Rhabdomyosarcoma
|
disease |
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |